Advancements in automation, artificial intelligence and high-throughput screening are streamlining the selection and optimization of cell lines, improving efficiency while reducing time and costs.

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already available, and adeno-associated virus (AAV) has become a popular choice for ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...

To achieve this progress, biologic production has had to reinvent itself. Although biologics were once sourced directly from donated blood plasma or cells, the backbone of this process is now a ...

NEWARK, Calif.--(BUSINESS WIRE)--ATUM, a leading US-based provider of integrated biologics solutions, proudly announces the launch of the CHO-K1-derived discoCHO™ cell line for transient protein ...

Maxwell has officially signed a full-line supply contract for Perovskite/SHJ tandem cells with a Chinese new energy company, ...